TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies. - Wikidata - awgldk - TriplyDB

TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.

TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.

http://www.wikidata.org/entity/Q37481085

about

Transcriptome sequencing of tumor subpopulations reveals a spectrum of therapeutic options for squamous cell lung cancer Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity Novel HTS strategy identifies TRAIL-sensitizing compounds acting specifically through the caspase-8 apoptotic axis.Beyond cell death - antiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitro A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase.Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling.Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines.Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist.Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody.HBV polymerase overexpression due to large core gene deletion enhances hepatoma cell growth by binding inhibition of microRNA-100.Targeting cell death signaling in colorectal cancer: current strategies and future perspectives.Targeting microRNAs to modulate TRAIL-induced apoptosis of cancer cells.Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment.A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma.ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein.shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis.Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers.Knockdown of HMGA1 expression by short/small hairpin RNA inhibits growth of ovarian carcinoma cells.

P2860

Q28488566-45AF1B47-54BD-4EC9-93C2-19C916032CB1 Q28729760-181F4B42-1356-4D58-9125-3FECA1ECCA45 Q30479062-1E4ECB10-6A7C-4D29-91CC-0096F92937C0 Q35009440-F6DBC3E9-A2E4-4083-9C0E-0C31936310D6 Q35038107-17A20B85-D2FC-4926-8BD6-F6E8FD596F37 Q35846545-8BFEAA09-9F27-46D7-B592-6884837E3159 Q36316437-86FF9524-1C45-433D-BF37-4653AABBED82 Q36392814-4A30B696-7E96-4BC0-B547-520972707AD9 Q36629288-A4B882A9-13F9-4457-8B7D-6C1B8381B902 Q36962637-E9B9FD75-3C94-474F-AEE6-F4903F80328B Q37602717-E4B08BD6-6832-4FF9-94DB-DD9C45E46820 Q38058733-F224773E-2C1C-4295-BB21-34561858A796 Q38233004-DCDB5D94-3F95-417B-A2DF-FAB599663003 Q38708598-86D87FCF-E658-47FD-BD15-DBC195AEFB48 Q39450845-F1767DC9-7C1B-4432-A25E-5D3E91768863 Q39520220-C753F28E-E93C-4428-967C-1A47FAD722D3 Q46107681-C2FAF4D1-3CF2-47E6-8987-60B233D01009 Q47109220-A3382608-311E-49BA-ABF3-CC2DC83ABF47 Q54324280-09822520-3BD5-4C7A-A761-51A83B6A40E4

P2860

TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.

http://www.wikidata.org/entity/Q37481085

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

TRAIL-induced apoptosis of hep ...... gmented by targeted therapies.

@en

TRAIL-induced apoptosis of hep ...... gmented by targeted therapies.

@nl

type

label

TRAIL-induced apoptosis of hep ...... gmented by targeted therapies.

@en

TRAIL-induced apoptosis of hep ...... gmented by targeted therapies.

@nl

prefLabel

TRAIL-induced apoptosis of hep ...... gmented by targeted therapies.

@en

TRAIL-induced apoptosis of hep ...... gmented by targeted therapies.

@nl

P1433

Q37481085-5F16E6B3-7F5A-420F-ABE6-5456EED68020

P1476

Q37481085-A77B43EC-AA73-41AD-B151-D926A9C999BC

P2093

Q37481085-1199C0AF-F7A1-4049-875F-72377265B22A

Q37481085-1D4208AC-D6CF-41B4-9E4B-F0ABF8BA97D6

Q37481085-3D914915-23C9-4F9A-A333-4A3C37E05492

Q37481085-93D29ED1-2267-4490-B950-8B1F60B5F123

Q37481085-AA30B527-4651-4393-9D7B-739A1CCECFFE

Q37481085-B58E9EC4-09B6-4816-A192-98FB0530CB1F

Q37481085-F01FE65A-ABCC-4C5A-9482-6A4C44B02699

P2860

Q37481085-0044456F-088A-4C1B-9249-2E672F10AE6B

Q37481085-046DD025-2FC7-47BA-8E70-9E68DC0CCBCF

Q37481085-086354B5-153B-4E2D-A6BE-3F03DAAF6E73

Q37481085-09E7D61E-0831-4277-8A37-AD9E3AA7D0C4

Q37481085-1364DA4F-EDEF-475F-A590-DB94E1AD2DE6

Q37481085-1375C1F9-52E2-423C-928F-00148D8ED9AF

Q37481085-13D74BE3-DD48-4ED5-83BC-03CB3CD07EB0

Q37481085-1579F9EF-DFA3-4A13-8EBA-57BA69A47536

Q37481085-1D4D8A41-C4AA-4862-A7ED-B1A8214D3EF8

Q37481085-2922C6BA-49B9-4100-8DC6-392C3C2DD720

P304

Q37481085-9DBAAD6C-AE31-474E-9941-6325A1050890

P31

Q37481085-2A89C21B-CEA2-4F65-9CB1-BBE442C8524F

P356

Q37481085-8D171ADB-58E1-4437-B354-F56616DCB141

P407

Q37481085-DDE155FC-4A80-4D7E-A1E6-91C4D14042B3

P433

Q37481085-40733790-4FEF-4F0A-B5A5-C38ED24BAB6D

P478

Q37481085-626995C9-8AA7-41B9-B525-F806A7A32DCB

P50

Q37481085-C96EFC65-D4FD-4188-BE38-76E5956C5015

P577

Q37481085-3A149DE7-4F3A-468F-88B2-AB756338DEF9

P698

Q37481085-E1CEE025-881B-403C-972A-0AC3397C9377

P921

Q37481085-FCAA7AB1-9CE7-45D2-9DEF-7B845E433A68

P932

Q37481085-8F3AE732-8A6B-4CDB-8A97-BBFA1D9FA886

P356

P1433

World Journal of Gastroenterology

P1476

TRAIL-induced apoptosis of hep ...... ugmented by targeted therapies

@en

P2093

Bruno-Christian Koehler

http://www.w3.org/2001/XMLSchema#string

Henning Schulze-Bergkamen

http://www.w3.org/2001/XMLSchema#string

Marcus Schuchmann

http://www.w3.org/2001/XMLSchema#string

Peter-R Galle

http://www.w3.org/2001/XMLSchema#string

Regina-Johanna Boger

http://www.w3.org/2001/XMLSchema#string

Steffen Heeger

http://www.w3.org/2001/XMLSchema#string

Toni Urbanik

http://www.w3.org/2001/XMLSchema#string

P2860

PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

A Brief History of Apoptosis: From Ancient to Modern Times

The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.

Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.

Epidemiology of primary liver cancer.

BH3 mimetic obatoclax enhances TRAIL-mediated apoptosis in human pancreatic cancer cells.

P304

5924-5935

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.15.5924

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20014456

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

2795179

http://www.w3.org/2001/XMLSchema#string